• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.

作者信息

Fragasso Alberto, Mannarella Clara, Ciancio Angela, Calvario Agata, Scarasciulli Maria Luisa

出版信息

Leuk Lymphoma. 2008 Nov;49(11):2224-6. doi: 10.1080/10428190802389835.

DOI:10.1080/10428190802389835
PMID:19021070
Abstract
摘要

相似文献

1
Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.在一名HIV阴性、HHV-8阳性的多中心Castleman病患者中，联合化疗免疫疗法（R-CVP）后序贯利妥昔单抗维持治疗实现完全缓解和病毒学应答。
Leuk Lymphoma. 2008 Nov;49(11):2224-6. doi: 10.1080/10428190802389835.
2
Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.一名全血细胞减少的HIV阴性、HHV-8阳性的多中心Castleman病患者经抗CD20治疗后完全缓解。
Clin Transl Oncol. 2006 Jul;8(7):540-1. doi: 10.1007/s12094-006-0056-2.
3
HIV-associated multicentric Castleman disease.人类免疫缺陷病毒相关多中心性Castleman病
Curr Opin HIV AIDS. 2009 Jan;4(1):16-21. doi: 10.1097/coh.0b013e328319bca9.
4
Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.在一名HHV8阳性、HIV阴性患者中，利妥昔单抗治疗使多中心Castleman病完全缓解后发生卡波西肉瘤。
Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.
5
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.利妥昔单抗用于经利妥昔单抗预处理的HIV相关多中心Castleman病的再次治疗。
Blood. 2007 Dec 1;110(12):4132-3. doi: 10.1182/blood-2007-08-106187.
6
Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.使用利妥昔单抗和脂质体阿霉素（一种新型化疗组合）使4例人疱疹病毒8相关多中心Castleman病患者完全缓解。
Clin Adv Hematol Oncol. 2012 Mar;10(3):204-6.
7
Brief communication: rituximab in HIV-associated multicentric Castleman disease.简短通讯：利妥昔单抗治疗HIV相关多中心Castleman病
Ann Intern Med. 2007 Dec 18;147(12):836-9. doi: 10.7326/0003-4819-147-12-200712180-00003.
8
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.HHV8 阳性、HIV 阴性多中心 Castleman 病：利妥昔单抗治疗的早期和持续完全缓解，无卡波西肉瘤再激活。
Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.
9
Rituximab therapy for HIV-associated Castleman disease.利妥昔单抗治疗HIV相关的卡波西肉瘤样血管内皮瘤病。
Blood. 2003 Oct 15;102(8):2786-8. doi: 10.1182/blood-2003-03-0951. Epub 2003 Jul 3.
10
Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient.成功治疗肝移植患者因 HHV-8 复发引起的医源性多中心 Castleman 病。
Am J Transplant. 2014 May;14(5):1207-13. doi: 10.1111/ajt.12693. Epub 2014 Mar 26.

引用本文的文献

1
Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.成功应用靶向治疗方法治疗一例伴有 TAFRO 综合征的白种人多中心 Castleman 病：病例报告。
Exp Hematol Oncol. 2015 Jan 14;4(1):3. doi: 10.1186/2162-3619-4-3. eCollection 2015.
2
Castleman's disease: from basic mechanisms to molecular therapeutics.卡斯尔曼病：从基础机制到分子治疗学。
Oncologist. 2011;16(4):497-511. doi: 10.1634/theoncologist.2010-0212. Epub 2011 Mar 25.
3
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
HHV8 阳性、HIV 阴性多中心 Castleman 病：利妥昔单抗治疗的早期和持续完全缓解，无卡波西肉瘤再激活。
Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.